Serum Institute Of India Pvt. Ltd.
Clinical trials sponsored by Serum Institute Of India Pvt. Ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Next-Generation polio vaccine enters human testing Results expected Nov 2026 (estimated)
- 5 years later: does one meningitis shot still shield? Results expected Dec 2026 (estimated)
- HPV vaccine trial aims to protect women with HIV from cervical cancer Results expected Dec 2026 (estimated)
-
HPV vaccine trial aims to protect women with HIV from cervical cancer
Vaccine OngoingThis study tests Cervavac, an HPV vaccine, in women aged 15-25 who are living with HIV. HPV infection can lead to cervical cancer, and women with HIV are at higher risk. The trial compares two-dose and three-dose schedules of Cervavac against a standard vaccine to see how well th…
Phase 3 • Sponsor: Serum Institute of India Pvt. Ltd. • Aim: Vaccine
Last updated Jul 01, 2026 00:00 UTC
-
Could a Dual-Action malaria vaccine end the cycle of transmission?
Prevention OngoingThis Phase 2 trial is testing a malaria vaccine that aims to both prevent infection and block the parasite from spreading to mosquitoes. Around 1,200 healthy participants aged 9 to 50 in Mali will receive either the R21 vaccine alone or a combination with Pfs230D1-CRM197, both wi…
Phase 2 • Sponsor: Serum Institute of India Pvt. Ltd. • Aim: Prevention
Last updated Jul 10, 2026 00:00 UTC